Recruiting

Observational Study

Sponsor:

Abramson Cancer Center at Penn Medicine

Code:

NCT05743049

Conditions

Pancreas Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Obtaining blood for analysis of various circulating biomarkers

Study Details

Brief summary:

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Conditions

Pancreas Cancer

Study ID

NCT05743049

Start date

Feb 27, 2023

Status verified date

Apr, 2026

Completion date

Jan 15, 2028

Anticipated

Primary completion date

Jun 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
  • The subject must be a patient of the University of Pennsylvania
  • The subject must be able to provide informed consent
  • The subject must be 18 years of age or older

Exclusion Criteria:

. Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.

Study Design

Enrollment

30 participants

Anticipated

Interventions and Outcome Measures

Arms

Blood specimens

Collection of blood for analysis of various circulating biomarkers in patients with pancreatic adenocarcinoma.

Interventions

Obtaining blood for analysis of various circulating biomarkers

4 tbsp of blood in a 1-week period, occurring no more frequently than 4 times in an 8-week period

Primary outcome measure

  • To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use. [ Time Frame: Through study completion, an average of 1 year ]

Central Contacts and Locations

Central contacts

Liudmila Mazaleuskaya, PhD

267-455-9141mazali@pennmedicine.upenn.edu

Mark O'Hara, MD

215-360-0919Mark.OHara@pennmedicine.upenn.edu

Locations

Abramson Cancer Center at University of Pennsylvania

Recruiting

Philadelphia, Pennsylvania, United States, 19104

More Information

Sponsor

Abramson Cancer Center at Penn Medicine

Last update posted

Apr 7, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine on 2026-04-07.